PDF) Acute lymphoblastic leukaemia: cyclical chemotherapy with three combinations of four drugs (COAP-POMP-CART regimen)
Cancer chemotherapy
PDF) Acute lymphoblastic leukaemia: cyclical chemotherapy with three combinations of four drugs (COAP-POMP-CART regimen | SUNIL PAREKH - Academia.edu
POMP combination chemotherapy of adult acute leukemia
Chemopomp: zo goed als nieuw - Amazing Erasmus MC
GAP-POMP regimen | Semantic Scholar
IJMS | Free Full-Text | Pathophysiological Potentials of NRF3-Regulated Transcriptional Axes in Protein and Lipid Homeostasis
Bortezomib resistance and POMP levels in myeloma cell lines. A,... | Download Scientific Diagram
Acute lymphoblastic leukaemia: cyclical chemotherapy with three combinations of four drugs (COAP-POMP-CART regimen). - Abstract - Europe PMC
Ionic Liquid-Modified Porous Organometallic Polymers as Efficient and Selective Photocatalysts for Visible-Light-Driven CO2 Reduction | Research
Chemotherapy agents and regimens used to treat LCH of the spine with... | Download Table
Hyper-CVAD regimen in combination with ofatumumab as frontline therapy for adults with Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia: a single-arm, phase 2 trial - The Lancet Haematology
Chemotherapy, Immunocompetence, Immunosuppression and Prognosis in Acute Leukemia | NEJM
Curative Treatment of POMP-Related Autoinflammation and Immune Dysregulation (PRAID) by Hematopoietic Stem Cell Transplantation | SpringerLink
PDF) Low nuclear MAD2 expression is associated with of lack of response to chemotherapy and radiotherapy in oestrogen receptor negative breast cancer patients | Malcolm Kell and Shiva Sharma - Academia.edu
Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000 | Leukemia
CHEMOTHERAPY IN CANCERS
Survivin-targeting Artificial MicroRNAs Mediated by Adenovirus Suppress Tumor Activity in Cancer Cells and Xenograft Models: Molecular Therapy - Nucleic Acids
What is the Future of Monoclonal Antibodies in Acute Lymphoblastic Leukemia?
